COVID-19NAD+:

Shixu Song1,2, Jialing Gan1,2, Qiuyue Long1,2

  • 1Department of Respiratory, Critical Care and Sleep Medicine, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361101, China.

Vaccines
|January 24, 2025
PubMed
概括

在COVID-19中研究尼古丁胺氨酸二核酸 (NAD+) 代谢揭示了潜在的治疗点. 调节NAD+通路可能会增强对SARS-CoV-2的免疫防御,提供新的治疗途径.